Knockout of A3 adenosine receptors reduces mouse intraocular pressure.
暂无分享,去创建一个
[1] W. Bao,et al. Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning. , 2001, Journal of molecular and cellular cardiology.
[2] P. Russell,et al. Development and Characterization of an Immortal and Differentiated Murine Trabecular Meshwork Cell Line , 2005 .
[3] S. Moro,et al. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. , 1999, Journal of medicinal chemistry.
[4] M. Jacobson,et al. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. , 2000, The Journal of clinical investigation.
[5] H. Gavras,et al. A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. , 2000, Biochimica et biophysica acta.
[6] Douglas R. Anderson,et al. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. , 1998, American journal of ophthalmology.
[7] Gauderman Wj,et al. Sample size calculations for ophthalmologic studies. , 1992 .
[8] Kyong-Tai Kim,et al. Pharmacological characterization of adenosine receptors in PGT‐β mouse pineal gland tumour cells , 2001, British journal of pharmacology.
[9] M. Civan,et al. Similarity of A(3)-adenosine and swelling-activated Cl(-) channels in nonpigmented ciliary epithelial cells. , 2000, American journal of physiology. Cell physiology.
[10] Beverly H. Koller,et al. Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells* , 2000, The Journal of Biological Chemistry.
[11] C. Crosson. Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: evidence for a dual mechanism of action. , 2001, Investigative ophthalmology & visual science.
[12] Z. Yang,et al. Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium. , 2001, American journal of physiology. Heart and circulatory physiology.
[13] K. Jacobson,et al. Pharmacological characterization of novel A3 adenosine receptor-selective antagonists , 1997, Neuropharmacology.
[14] Michael G. Anderson,et al. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice , 1999, Nature Genetics.
[15] D. Snydacker,et al. Adler's Physiology of the Eye. Clinical Application , 1981 .
[16] W. Barlow,et al. Sample size calculations for ophthalmologic studies. , 1992, Archives of ophthalmology.
[17] Douglas R. Anderson,et al. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. , 1998, American journal of ophthalmology.
[18] P. Kaufman,et al. Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys. , 1997, Experimental eye research.
[19] C. Crosson. Adenosine receptor activation modulates intraocular pressure in rabbits. , 1995, The Journal of pharmacology and experimental therapeutics.
[20] J. Linden. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.
[21] M. Civan,et al. Reliable measurement of mouse intraocular pressure by a servo-null micropipette system. , 2001, Investigative ophthalmology & visual science.
[22] B. Prum,et al. The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration , 2000 .
[23] K. Jacobson,et al. Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells. , 2000, The Journal of membrane biology.
[24] M. Civan,et al. Similarity of A3-adenosine and swelling-activated Cl− channels in nonpigmented ciliary epithelial cells , 2000 .
[25] R. Stone,et al. A1‐, A2A‐ and A3‐subtype adenosine receptors modulate intraocular pressure in the mouse , 2001, British journal of pharmacology.
[26] R. Stone,et al. A3 adenosine receptors regulate Cl-channels of nonpigmented ciliary epithelial cells. , 1999, American journal of physiology. Cell physiology.
[27] S. Moro,et al. Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. , 1998, Journal of medicinal chemistry.
[28] C. Crosson,et al. Characterization of ocular hypertension induced by adenosine agonists. , 1996, Investigative ophthalmology & visual science.
[29] R. Stone,et al. Inhibitors of NHE-1 Na+/H+ exchange reduce mouse intraocular pressure. , 2002, Investigative ophthalmology & visual science.